Cancer
Breakthroughs in Personalized Medicine: Neoantigen Identification and TCR-T Therapy Development
Researchers from the State Key Laboratory of Molecular Oncology have made significant strides in personalized medicine, focusing on the identification and targeting of neoantigens in solid tumors. This promising approach utilizes T cell receptor (TCR-T) cells, engineered to selectively kill tumor cells while minimizing damage to healthy cells. The study,